Abstract:Abstract Background: Despite the changing landscape of treatment of chronic lymphoma leukemia (CLL) and in contrast to the large number of quality of life (QoL) and psychosocial studies in patients with solid tumors, relatively few studies have reported QoL in patients with CLL. This study aims to assess depression, anxiety, stress and QoL in a Chinese CLL cohort. Patients and Methods: Taking advantage of the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 accompanying CLL-specific module QLQ-CLL17 questionnaire and DASS-21 questionnaire, a total of 50 Chinese patients with CLL completed self-reported questionnaires from December 2019 to July 2021, assessing the level of depression, anxiety, stress and QoL. Results: Among the 50 CLL patients, 34 patients were male. The median age was 57 (22-77) years old. 66% of the patients were uncertain about the staging of the disease. 36% of the patients were uncertain about therapeutic implications of CLL. According to EORTC QLQ-C30, patients had low level of physical functioning, role functioning, emotional functioning, cognitive functioning and social functioning were 80%, 32%, 68%, 66%, 64%, respectively. Patients in active-treatment group had significantly lower level of physical function than "watch and wait" group (90% vs. 65%, P=0.03). The proportion of patients with cognitive problems was significantly higher in female patients than in male patients (93.8% vs. 52.9%, P=0.004). According to QLQ-CLL17, patients with symptom burden, physical condition and worries about health were 94% (47/50), 86% (43/50), 98% (48/50). Patients under 60 years old had higher scores for worries about health than patients older than 60. According to DASS-21 questionnaire, 86% of the patients had depression symptomatic scores (mild grade: 2%, medium grade: 52%, severe grade: 20%, very severe grade: 12%). 84% of the patients had anxiety symptomatic scores ( mild grade: 6%, medium grade: 14%, severe grade: 30%, very severe grade: 34%). 64% of the patients had stress symptomatic scores ( mild grade: 18%, medium grade: 22%, severe grade: 16%, very severe grade: 8%). And these psychosocial issues had no significant correlation with gender, age, household income and treatment . The same questionnaires were completed by 5 patients for the second time after median 8(2-18)months. Compared to the initial assessment, they scored significantly worse on the emotional scales (P=0.0237). No significant difference regarding physical functioning, role functioning, cognitive functioning and social functioning were observed between the former and the latter. Conclusions: The majority of CLL patients had impaired QoL and psychosocial issues. Active-treatment patients had worse physical condition than "watch and wait" patients. Male patients had better cognitive functioning. Younger patients had more worries about health than the elderly. Greater efforts should be made in management of CLL patients. Disclosures No relevant conflicts of interest to declare.

Validation of Eortc Qlq-Lc43 for Chinese Patients with Lung Cancer

Validation of the Chinese version of EORTC QLQ-BM22 in patients with bone metastases

Cross-cultural verification of the EORTC QLQ-C15-PAL questionnaire in mainland China

Validation of EORTC IN-PATSAT32 for Chinese cancer patients

Validation of COPD Population Screener Questionnaire in Chinese Population: A National Multicenter Study

Reliability and Validity of Self-made Life Quality Questionnaire of Lung Cancer patients

Development and Evaluation on Chinese Version of Measurement Instrument of Quality of Life for Patients with Stomach Cancer:EORTC QLQ-STO22

Validity and reliability of the simplified Chinese patient-reported outcomes version of the common terminology criteria for adverse events

Development and initial validation of the chronic hepatitis B quality of life instrument (CHBQOL) among Chinese patients

Development and Validation of the Simplified Chinese Version of EORTC QLQ-H&N35 for Patients with Head and Neck Cancer

Validation of the functional assessment of cancer therapy-gastric module for the Chinese population

Validation of the Chinese version of the Head and Neck Patient Symptom Checklist for measuring nutrition impact symptoms during radiotherapy in patients with head and neck cancer

[DESCRIPTION OF IXODES BRUMPTI N. SP. (ACARIDAE, IXODOIDEA) FROM THE HYRAX OF HARRAR (ETHIOPIA)].

Assessment of Quality of Life in Chinese Patients with Chronic Lymphocytic Leukemia

Early Results of Quality of Life for Curatively Treated Rectal Cancers in Chinese Patients with Eortc Qlq-Cr29

[Development of a quality of life instrument for evaluation of the quality of life scale for Chinese patients with oral cancer]

Psychometric evaluation of the Chinese version of the Upper Limb Lymphedema Quality of Life Questionnaire in breast cancer-related lymphedema patients

The Chinese Thoracic Oncology Group (CTONG) Therapeutic Option Scoring System: a Multiple-Parameter Framework to Assess the Value of Lung Cancer Treatment Options

Ionic effects on the motility of bull and chimpanzee spermatozoa.

Psychometric Properties of Chinese Version SF-36 for Measuring Quality of Life in Patients with Oral Cancer

Comparing the EORTC QLQ-LC13, EORTC QLQ-LC29, and the FACT-L for assessment of quality of life in patients with lung cancer - an updated systematic review